Blood test may predict lung transplant or death risk in PH patients
NCT ID NCT07253363
First seen Jan 05, 2026 · Last updated May 25, 2026 · Updated 27 times
Summary
This study is looking at two substances in the blood, Activin-A and FSTL3, to see if they can help predict how people with pulmonary hypertension (high blood pressure in the lungs) will do over time. Researchers will follow 550 adults with different types of this condition for two years. The goal is to see if these markers can forecast the need for a lung transplant or death, which could help doctors make better treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Bicêtre (AP-HP.Université Paris-Saclay), Service de Pneumologie et Soins Intensifs
Le Kremlin-Bicêtre, France, 94270, France
Conditions
Explore the condition pages connected to this study.